Net cash proceeds from XPDI merger
Company: Core Scientific
The claim, verbatim
The merger provided approximately $195.0 million in net cash proceeds to Core Scientific after payment of transaction expenses.
Source (primary)
Core Scientific 424B3 filed 2022-08-22 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “The Merger provided gross proceeds of approximately $221.6 million from the XPDI trust account, resulting in approximately $195.0 million in net cash proceeds to Core Scientific, after the payment of transaction expenses”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific 424B3 filed 2022-08-22
Quote: “The Merger provided gross proceeds of approximately $221.6 million from the XPDI trust account, resulting in approximately $195.0 million in net cash proceeds to Core Scientific, after the payment of transaction expenses”